Apo-tiotropium Capsules; Out-of-specification (particle Size)
Apo-Tiotropium 18 mcg Capsules are being recalled across Canada because the particles in the capsules are larger than they should be. This is a quality issue that affects how the medication works in the body. The recall applies to all Apo-Tiotropium 18 mcg Capsules distributed in Canada.
- Product
- Apo-Tiotropium 18 mcg Capsules
- Reason
- Product quality concern
- Classification
- Class II
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-07-13
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/243c2b2c-4351-45ef-bb0a-49ac6120a09a